Sorry, you need to enable JavaScript to visit this website.

Aurobindo Pharma's three units in Telangana gets VAI classification by USFDA, shares gain

VAI means USFDA will not take regulatory action because the objectionable conditions if found are minor and may not qualify for enforcement action. The three units that were classified as VAI are Unit I and Unit-III, manufacture tablets, capsules and soft gel Capsules and a Derma manufacturing facility. All the three units are located at Jadcherla, Mahabubnagar District, Telangana.

Read more at: